Fresenius Medical Care

$34.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-1.51%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FMS and other stocks, options, and ETFs commission-free!

About FMS

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany. The listed name for FMS is Fresenius Medical Care AG & Co. KGaA.

CEO
Rice Powell
Employees
120,659
Headquarters
Bad Homburg, Hessen
Founded
2006
Market Cap
20.35B
Price-Earnings Ratio
15.52
Dividend Yield
1.42
Average Volume
707.78K
High Today
$34.84
Low Today
$34.43
Open Price
$34.66
Volume
279.66K
52 Week High
$46.55
52 Week Low
$29.17

FMS News

BenzingaFeb 23

Recap: Fresenius Medical Care Q4 Earnings

Shares of Fresenius Medical Care (NYSE:FMS) rose 0.0% after the company reported Q4 results. Quarterly Results Earnings per share fell 50.00% year over year t
MarketWatchFeb 23

Fresenius confirms view despite virus headwinds

--Fresenius has confirmed its 2021 guidance as well as targets until 2023 --Net profit declined slightly in the fourth quarter on flat sales --Fresenius is la
ReutersFeb 23

UPDATE 3-Fresenius reviews company structure after COVID-19 hit

* Plans to review operations, cut costs to keep mid-term goals * No immediate spin-off plans but keeping long-term options open * More details to follow on Ma

FMS Earnings

$0.47
$0.82
$1.17
$1.52
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$0.77 per share
Actual
$0.76 per share
Replay Earnings Call

You May Also Like

SOJE

More FMS News

ReutersFeb 23

Fresenius Medical Care sees weak H1 as coronavirus weighs

Feb 23 (Reuters) - German dialysis specialist Fresenius Medical Care said on Tuesday it expected the heavy death toll among its patients, which dented its full-
ReutersFeb 23

REFILE-Fresenius specifies 2021 outlook amid COVID-19 uncertainty

(Fixes headline) Feb 23 (Reuters) - German healthcare group Fresenius narrowed down its 2021 sales growth forecast as it reported a slight full-year results be
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure